10-Q · 2026-11-12
Artelo Biosciences, Inc. releases its Q3 2026 financial report, providing insights into its performance and strategies in the pharmaceutical preparations industry.
| Name | ARTELO BIOSCIENCES, INC. |
|---|---|
| CIK | 0001621221 |
| Tickers | ARTL |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 331220924 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | NV NV |
| Phone | 858-925-7049 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Artelo Biosciences, Inc. releases its Q3 2026 financial report, providing insights into its performance and strategies in the pharmaceutical preparations industry.
Artelo Biosciences may face delisting from Nasdaq due to a new rule requiring a minimum market value of listed securities. The company is exploring compliance strategies.
466 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-12 | 10-Q | FORM 10-Q | 0001640334-26-001776 | 001-38951 | 261543427 | 34 | 4777308 | 1 | 1 | |
| 2026-10-09 | 8-K | FORM 8-K | 8.01 | 0001640334-26-001665 | 001-38951 | 261453695 | 34 | 143795 | 1 | 1 |
| 2026-08-27 | 8-K | FORM 8-K | 3.03,5.03,7.01,9.01 | 0001640334-26-001421 | 001-38951 | 261325289 | 34 | 721652 | 1 | 1 |
| 2026-08-20 | 10-Q/A | FORM 10-Q/A | 0001640334-26-001400 | 001-38951 | 261300323 | 34 | 234696 | 1 | 1 | |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003551 | 005-90653 | 261277006 | 34 | 10728 | |||
| 2026-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001213900-26-088826 | 005-90653 | 261270831 | 34 | 10519 | |||
| 2026-08-12 | 10-Q | FORM 10-Q | 0001640334-26-001323 | 001-38951 | 261268053 | 34 | 6183178 | 1 | 1 | |
| 2026-07-21 | 4 | FORM 4 | 0001640334-26-001231 | 13928 | ||||||
| 2026-07-21 | 4 | FORM 4 | 0001640334-26-001229 | 13737 | ||||||
| 2026-07-21 | 4 | FORM 4 | 0001640334-26-001227 | 13807 | ||||||
| 2026-07-21 | 4 | FORM 4 | 0001640334-26-001225 | 13807 | ||||||
| 2026-07-21 | 4 | FORM 4 | 0001640334-26-001223 | 13834 | ||||||
| 2026-07-21 | 4 | FORM 4 | 0001640334-26-001221 | 13912 | ||||||
| 2026-07-17 | 8-K | FORM 8-K | 5.07 | 0001640334-26-001198 | 001-38951 | 261184136 | 34 | 150254 | 1 | 1 |
| 2026-07-16 | DEFA14A | DEFA14A | 0001640334-26-001189 | 001-38951 | 261179554 | 34 | 27844 | |||
| 2026-07-16 | DEFA14A | DEFA14A | 0001640334-26-001186 | 001-38951 | 261178312 | 34 | 218090 | |||
| 2026-07-02 | DEFA14A | DEFA14A | 0001640334-26-001147 | 001-38951 | 261150961 | 34 | 475077 | |||
| 2026-06-22 | PRER14A | PRER 14A | 0001640334-26-001106 | 001-38951 | 261107026 | 34 | 73667 | |||
| 2026-06-05 | ARS | ARS | 0001640334-26-001011 | 001-38951 | 261069099 | 34 | 12145134 | |||
| 2026-06-05 | DEFA14A | DEFA14A | 0001640334-26-001009 | 001-38951 | 261069070 | 34 | 364661 | |||
| 2026-06-05 | DEF 14A | DEF 14A | 0001640334-26-001007 | 001-38951 | 261069024 | 34 | 2901061 | 1 | 1 | |
| 2026-05-27 | 8-K | FORM 8-K | 1.01,8.01,9.01 | 0001640334-26-000973 | 001-38951 | 261026923 | 34 | 441116 | 1 | 1 |
| 2026-05-26 | PRE 14A | FORM PRE 14A | 0001640334-26-000969 | 001-38951 | 261020954 | 34 | 2917402 | 1 | 1 | |
| 2026-05-26 | 424B5 | 424B5 | 0001640334-26-000966 | 333-295537 | 261020696 | 33 | 424666 | |||
| 2026-05-19 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001705 | 333-295537 | 261001268 | 33 | 1942 | ||
| 2026-05-18 | 424B5 | FORM 424B5 | 0001640334-26-000926 | 333-273153 | 26994051 | 33 | 16657 | |||
| 2026-05-15 | CORRESP | filename1.htm | 0001640334-26-000905 | 6277 | ||||||
| 2026-05-15 | 8-K | FORM 8-K | 1.02 | 0001640334-26-000903 | 001-38951 | 26986591 | 34 | 141203 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-002123 | 005-90653 | 26984001 | 34 | 10583 | |||
| 2026-05-14 | 10-Q | FORM 10-Q | 0001640334-26-000869 | 001-38951 | 26978806 | 34 | 8675712 | 1 | 1 | |
| 2026-05-14 | S-3/A | FORM S-3/A | 0001640334-26-000867 | 333-295537 | 26978507 | 33 | 367764 | |||
| 2026-05-11 | UPLOAD | filename1.pdf | 0000000000-26-004788 | 333-295537 | 147645 | |||||
| 2026-05-04 | S-3 | FORM S-3 | 0001640334-26-000820 | 333-295537 | 26938552 | 33 | 526494 | 1 | 1 | |
| 2026-04-16 | 424B3 | 424B3 | 0001640334-26-000761 | 333-294912 | 26865706 | 33 | 240984 | |||
| 2026-04-15 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001202 | 333-294912 | 26865543 | 33 | 1941 | ||
| 2026-04-13 | CORRESP | filename1.htm | 0001640334-26-000693 | 4593 | ||||||
| 2026-04-13 | UPLOAD | filename1.pdf | 0000000000-26-003674 | 333-294912 | 40264 | |||||
| 2026-04-07 | S-1 | FORM S-1 | 0001640334-26-000670 | 333-294912 | 26845170 | 33 | 648664 | 1 | 1 | |
| 2026-04-07 | 8-K | FORM 8-K | 8.01,9.01 | 0001640334-26-000662 | 001-38951 | 26842951 | 34 | 164434 | 1 | 1 |
| 2026-04-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001621221-26-000005 | 021-579170 | 26840290 | 33 | 13531 | ||
| 2026-04-03 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001213900-26-039993 | 005-90653 | 26838704 | 34 | 15732 | |||
| 2026-03-30 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001002 | 333-294579 | 26816643 | 33 | 1941 | ||
| 2026-03-30 | 8-K | FORM 8-K | 1.01,3.02,7.01,8.01,9.01 | 0001640334-26-000574 | 001-38951 | 26813640 | 34 | 974060 | 1 | 1 |
| 2026-03-27 | D | xslFormDX01/primary_doc.xml | 06b | 0001621221-26-000004 | 021-578154 | 26808351 | 33 | 12245 | ||
| 2026-03-27 | D | xslFormDX01/primary_doc.xml | 06b | 0001621221-26-000003 | 021-578152 | 26808328 | 33 | 12245 | ||
| 2026-03-27 | D | xslFormDX01/primary_doc.xml | 06b | 0001621221-26-000002 | 021-578151 | 26808315 | 33 | 12299 | ||
| 2026-03-27 | RW | FORM RW | 0001640334-26-000558 | 333-294506 | 26801120 | NE | 9460 | |||
| 2026-03-26 | 8-K | FORM 8-K | 1.01,3.02,7.01,9.01 | 0001640334-26-000554 | 001-38951 | 26799130 | 34 | 531847 | 1 | 1 |
| 2026-03-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000932 | 333-294506 | 26794179 | 33 | 1941 | ||
| 2026-03-25 | CORRESP | filename1.htm | 0001640334-26-000547 | 6278 | ||||||
| 2026-03-24 | S-1 | FORM S-1 | 0001640334-26-000543 | 333-294579 | 26787689 | 33 | 683373 | 1 | 1 | |
| 2026-03-24 | S-1/A | FORM-S-1/A | 0001640334-26-000540 | 333-294506 | 26787381 | 33 | 615270 | |||
| 2026-03-23 | S-1/A | FORM-S-1/A | 0001640334-26-000515 | 333-294506 | 26783368 | 33 | 437390 | |||
| 2026-03-20 | CORRESP | filename1.htm | 0001640334-26-000508 | 5395 | ||||||
| 2026-03-20 | CORRESP | filename1.htm | 0001640334-26-000506 | 8401 | ||||||
| 2026-03-20 | S-1 | FROM-S-1 | 0001640334-26-000502 | 333-294506 | 26779190 | 33 | 1111292 | 1 | 1 | |
| 2026-03-18 | 8-K | FORM 8-K | 1.01,3.02,9.01 | 0001640334-26-000475 | 001-38951 | 26770191 | 34 | 508688 | 1 | 1 |
| 2026-03-17 | 8-K | FORM 8-K | 2.02,8.01,9.01 | 0001640334-26-000461 | 001-38951 | 26762867 | 34 | 3956483 | 1 | 1 |
| 2026-03-13 | UPLOAD | filename1.pdf | 0000000000-26-002625 | 377-09128 | 40573 | |||||
| 2026-03-09 | DRS | filename1.htm | 0001640334-26-000403 | 377-09128 | 26736253 | 33 | 519352 | |||
| 2026-03-06 | 8-K | FORM 8-K | 3.03,5.03,8.01,9.01 | 0001640334-26-000395 | 001-38951 | 26728549 | 34 | 531952 | 1 | 1 |
| 2026-02-24 | 10-K | FORM 10-K | 0001640334-26-000368 | 001-38951 | 26667597 | 34 | 5231301 | 1 | 1 | |
| 2026-02-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001621221-26-000001 | 021-572642 | 26604291 | 33 | 12395 | ||
| 2026-02-05 | 8-K | FORM 8-K | 1.01,3.02,9.01 | 0001640334-26-000227 | 001-38951 | 26602794 | 34 | 671036 | 1 | 1 |
| 2026-02-05 | 8-K | FORM 8-K | 8.01 | 0001640334-26-000221 | 001-38951 | 26600599 | 34 | 145330 | 1 | 1 |
| 2026-02-02 | 4 | FORM 4 | 0001640334-26-000199 | 5923 | ||||||
| 2026-02-02 | 4 | FORM 4 | 0001640334-26-000198 | 5980 | ||||||
| 2026-02-02 | 4 | FORM 4 | 0001640334-26-000197 | 5959 | ||||||
| 2026-02-02 | 4 | FORM 4 | 0001640334-26-000196 | 5984 | ||||||
| 2026-02-02 | 4 | FORM 4 | 0001640334-26-000195 | 6062 | ||||||
| 2026-02-02 | 4 | FORM 4 | 0001640334-26-000194 | 5945 | ||||||
| 2026-02-02 | 4 | FORM 4 | 0001640334-26-000193 | 6037 | ||||||
| 2026-02-02 | 4 | FORM 4 | 0001640334-26-000192 | 6040 | ||||||
| 2026-01-30 | 8-K | FORM 8-K | 5.07 | 0001640334-26-000181 | 001-38951 | 26583482 | 34 | 148727 | 1 | 1 |
| 2026-01-16 | 8-K | FORM 8-K | 3.01 | 0001640334-26-000109 | 001-38951 | 26540387 | 34 | 143128 | 1 | 1 |
| 2026-01-07 | DEFA14A | DEFA 14A | 0001640334-26-000049 | 001-38951 | 26515754 | 34 | 510842 | |||
| 2026-01-02 | 8-K | FORM 8-K | 7.01 | 0001640334-26-000005 | 001-38951 | 26502596 | 34 | 143155 | 1 | 1 |
| 2025-12-11 | ARS | ANNUAL REPORT TO SECURITY HOLDERS | 0001640334-25-002309 | 001-38951 | 251565139 | 34 | 969016 | |||
| 2025-12-11 | DEF 14A | DEF 14A | 0001640334-25-002308 | 001-38951 | 251564998 | 34 | 1559891 | 1 | 1 | |
| 2025-12-02 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003484 | 333-291597 | 251544872 | 33 | 1942 | ||
| 2025-12-01 | CORRESP | filename1.htm | 0001640334-25-002233 | 8251 | ||||||
| 2025-11-25 | 8-K | FORM 8-K | 3.01 | 0001640334-25-002210 | 001-38951 | 251521051 | 34 | 142960 | 1 | 1 |
| 2025-11-17 | 3 | PRIMARY DOCUMENT | 0001640334-25-002155 | 6267 | ||||||
| 2025-11-17 | S-1 | FORM S-1 | 0001640334-25-002154 | 333-291597 | 251491690 | 33 | 985974 | 1 | 1 | |
| 2025-11-14 | 8-K | FORM 8-K | 5.03,9.01 | 0001640334-25-002118 | 001-38951 | 251485996 | 34 | 151047 | 1 | 1 |
| 2025-11-12 | 10-Q | FORM 10-Q | 0001640334-25-002022 | 001-38951 | 251469052 | 34 | 4120787 | 1 | 1 | |
| 2025-11-10 | D | xslFormDX01/primary_doc.xml | 06b | 0001640334-25-001998 | 021-563578 | 251465904 | 33 | 11961 | ||
| 2025-10-31 | 8-K | FORM 8-K | 1.01,2.03,3.02,9.01 | 0001640334-25-001930 | 001-38951 | 251437971 | 34 | 406879 | 1 | 1 |
| 2025-10-30 | 4 | FORM 4 | 0001640334-25-001925 | 13320 | ||||||
| 2025-10-30 | 4 | FORM 4 | 0001640334-25-001923 | 13451 | ||||||
| 2025-10-30 | 4 | FORM 4 | 0001640334-25-001921 | 13388 | ||||||
| 2025-10-27 | 8-K | FORM 8-K | 5.02,9.01 | 0001640334-25-001880 | 001-38951 | 251417518 | 34 | 404474 | 1 | 1 |
| 2025-10-21 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000921895-25-002780 | 005-90653 | 251408175 | 34 | 11718 | |||
| 2025-10-17 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000921895-25-002763 | 005-90653 | 251401448 | 34 | 258220 | |||
| 2025-10-17 | 8-K | FORM 8-K | 1.01,9.01 | 0001640334-25-001856 | 001-38951 | 251401183 | 34 | 247449 | 1 | 1 |
| 2025-10-03 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000921895-25-002691 | 005-90653 | 251375014 | 34 | 8561 | |||
| 2025-10-01 | 8-K | FORM 8-K | 1.01,7.01,9.01 | 0001640334-25-001766 | 001-38951 | 251365691 | 34 | 679584 | 1 | 1 |
| 2025-10-01 | 424B5 | 424B5 | 0001640334-25-001763 | 333-273153 | 251363143 | 33 | 539461 | |||
| 2025-09-30 | 424B5 | 424B5 | 0001640334-25-001749 | 333-273153 | 251358161 | 33 | 562905 | |||
| 2025-09-30 | 424B5 | 424B5 | 0001640334-25-001747 | 333-273153 | 251358157 | 33 | 18243 | |||
| 2025-09-29 | DRS | filename1.htm | 0001640334-25-001740 | 377-08523 | 251356305 | 33 | 562011 | |||
| 2025-09-19 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0000921895-25-002596 | 005-90653 | 251325605 | 34 | 64448 | |||
| 2025-09-15 | 8-K | FORM 8-K | 8.01,9.01 | 0001640334-25-001680 | 001-38951 | 251314499 | 34 | 144829 | 1 | 1 |
| 2025-09-10 | 8-K | FORM 8-K | 5.03,9.01 | 0001640334-25-001660 | 001-38951 | 251304700 | 34 | 160275 | 1 | 1 |
| 2025-09-05 | 8-K | FORM 8-K | 1.01,7.01,9.01 | 0001640334-25-001642 | 001-38951 | 251297496 | 34 | 674799 | 1 | 1 |
| 2025-09-05 | 424B5 | 424B5 | 0001640334-25-001629 | 333-273153 | 251295602 | 33 | 557748 | |||
| 2025-09-04 | 424B5 | 424B5 | 0001640334-25-001624 | 333-273153 | 251291904 | 33 | 560218 | |||
| 2025-09-04 | 424B5 | 424B5 | 0001640334-25-001622 | 333-273153 | 251291888 | 33 | 18499 | |||
| 2025-09-03 | 8-K | FORM 8-K | 8.01 | 0001640334-25-001617 | 001-38951 | 251291196 | 34 | 145630 | 1 | 1 |
| 2025-08-29 | 8-K | FORM 8-K | 5.07 | 0001640334-25-001613 | 001-38951 | 251281576 | 34 | 151765 | 1 | 1 |
| 2025-08-20 | 8-K | FORM 8-K | 1.02,9.01 | 0001640334-25-001570 | 001-38951 | 251237203 | 34 | 222279 | 1 | 1 |
| 2025-08-13 | D | xslFormDX01/primary_doc.xml | 06b | 0001786236-25-000029 | 021-554520 | 251209247 | 33 | 11544 | ||
| 2025-08-13 | 10-Q | FORM 10-Q | 0001640334-25-001429 | 001-38951 | 251209044 | 34 | 4066170 | 1 | 1 | |
| 2025-08-07 | DEF 14A | DEF 14A | 0001640334-25-001376 | 001-38951 | 251194070 | 34 | 1865666 | |||
| 2025-08-07 | 8-K | FORM 8-K | 1.01,3.02,9.01 | 0001640334-25-001375 | 001-38951 | 251193789 | 34 | 306480 | 1 | 1 |
| 2025-08-04 | 8-K | FORM 8-K | 1.01,3.02,7.01,8.01,9.01 | 0001640334-25-001334 | 001-38951 | 251178027 | 34 | 833448 | 1 | 1 |
| 2025-07-28 | PRE 14A | PRE 14A | 0001640334-25-001329 | 001-38951 | 251155585 | 34 | 1848113 | |||
| 2025-07-18 | 8-K | FORM 8-K | 1.01,9.01 | 0001640334-25-001240 | 001-38951 | 251134906 | 34 | 456867 | 1 | 1 |
| 2025-07-18 | 424B5 | 424B5 | 0001640334-25-001239 | 333-273153 | 251134904 | 33 | 305851 | |||
| 2025-07-17 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002274 | 333-288653 | 251132549 | 33 | 1942 | ||
| 2025-07-16 | CORRESP | filename1.htm | 0001640334-25-001219 | 7531 | ||||||
| 2025-07-16 | UPLOAD | filename1.pdf | 0000000000-25-007505 | 333-288653 | 40279 | |||||
| 2025-07-11 | S-1 | FORM S-1 | 0001640334-25-001190 | 333-288653 | 251119773 | 33 | 470309 | |||
| 2025-07-11 | 8-K | FORM 8K | 2.02,8.01,9.01 | 0001640334-25-001184 | 001-38951 | 251119383 | 34 | 4684771 | 1 | 1 |
| 2025-07-09 | D | xslFormDX01/primary_doc.xml | 06b | 0001640334-25-001156 | 021-551162 | 251113512 | 33 | 11112 | ||
| 2025-07-07 | 4 | PRIMARY DOCUMENT | 0001640334-25-001136 | 8448 | ||||||
| 2025-06-26 | 8-K | FORM 8-K | 1.01,3.02,7.01,9.01 | 0001640334-25-001062 | 001-38951 | 251075087 | 34 | 691123 | 1 | 1 |
| 2025-06-13 | 8-K | FORM 8-K | 3.03,5.03,8.01,9.01 | 0001640334-25-001046 | 001-38951 | 251047646 | 34 | 513993 | 1 | 1 |
| 2025-05-23 | 8-K | FORM 8-K | 3.01 | 0001640334-25-000935 | 001-38951 | 25982890 | 34 | 143304 | 1 | 1 |
| 2025-05-13 | 10-Q | FORM 10-Q | 0001640334-25-000825 | 001-38951 | 25937317 | 34 | 3312637 | 1 | 1 | |
| 2025-05-05 | 4 | FORM 4 | 0001640334-25-000789 | 7887 | ||||||
| 2025-05-05 | 4 | FORM 4 | 0001640334-25-000788 | 7634 | ||||||
| 2025-05-05 | 4 | FORM 4 | 0001640334-25-000787 | 7711 | ||||||
| 2025-05-01 | 8-K | FORM 8-K | 1.01,3.02,9.01 | 0001640334-25-000732 | 001-38951 | 25903518 | 34 | 371803 | 1 | 1 |
| 2025-04-29 | 8-K | FORM 8-K | 3.01 | 0001640334-25-000719 | 001-38951 | 25887677 | 34 | 151803 | 1 | 1 |
| 2025-03-20 | S-8 | FORM 8-K | 0001640334-25-000439 | 333-285934 | 25754360 | 33 | 68734 | |||
| 2025-03-03 | 10-K | FORM 10-K | 0001640334-25-000335 | 001-38951 | 25693837 | 34 | 5016085 | 1 | 1 | |
| 2024-12-23 | 4 | FORM 4 | 0001640334-24-001935 | 5936 | ||||||
| 2024-12-23 | 4 | FORM 4 | 0001640334-24-001933 | 5993 | ||||||
| 2024-12-23 | 4 | FORM 4 | 0001640334-24-001931 | 5958 | ||||||
| 2024-12-23 | 4 | FORM 4 | 0001640334-24-001929 | 5860 | ||||||
| 2024-12-23 | 4 | FORM 4 | 0001640334-24-001927 | 5997 | ||||||
| 2024-12-23 | 4 | FORM 4 | 0001640334-24-001925 | 6075 | ||||||
| 2024-12-20 | 8-K | FORM 8-K | 5.07 | 0001640334-24-001915 | 001-38951 | 241568564 | 34 | 156071 | 1 | 1 |
| 2024-11-12 | 10-Q | FORM 10-Q | 0001640334-24-001677 | 001-38951 | 241443555 | 34 | 3667610 | 1 | 1 | |
| 2024-11-08 | DEFA14A | DEFA 14A | 0001640334-24-001672 | 001-38951 | 241441157 | 34 | 733547 | |||
| 2024-11-08 | DEF 14A | DEF 14A | 0001640334-24-001670 | 001-38951 | 241441125 | 34 | 509175 | |||
| 2024-11-08 | ARS | ARS | 0001640334-24-001669 | 001-38951 | 241441080 | 34 | 1341188 | |||
| 2024-08-13 | 10-Q | FORM 10-Q | 0001640334-24-001221 | 001-38951 | 241198865 | 34 | 3722814 | 1 | 1 | |
| 2024-06-17 | 25-NSE | xslF25X02/primary_doc.xml | 0001354457-24-000412 | 001-38951 | 241049405 | 34 | 3205 | |||
| 2024-05-13 | 10-Q | FORM 10-Q | 0001640334-24-000757 | 001-38951 | 24937146 | 34 | 3437680 | 1 | 1 | |
| 2024-03-29 | S-8 | S-8 | 0001640334-24-000520 | 333-278359 | 24801591 | 33 | 77464 | |||
| 2024-03-25 | 10-K | FORM 10-K | 0001640334-24-000473 | 001-38951 | 24776921 | 34 | 4841442 | 1 | 1 | |
| 2024-03-04 | 8-K | FORM 8-K | 5.02 | 0001640334-24-000345 | 001-38951 | 24715241 | 34 | 172989 | 1 | 1 |
| 2024-03-01 | 4 | PRIMARY DOCUMENT | 0001640334-24-000335 | 28403 | ||||||
| 2024-03-01 | 4 | PRIMARY DOCUMENT | 0001640334-24-000334 | 36586 | ||||||
| 2024-03-01 | 4 | PRIMARY DOCUMENT | 0001640334-24-000333 | 32177 | ||||||
| 2024-03-01 | 4 | PRIMARY DOCUMENT | 0001640334-24-000332 | 29100 | ||||||
| 2024-03-01 | 4 | PRIMARY DOCUMENT | 0001640334-24-000331 | 28033 | ||||||
| 2024-03-01 | 4 | PRIMARY DOCUMENT | 0001640334-24-000330 | 32173 | ||||||
| 2024-03-01 | 4 | PRIMARY DOCUMENT | 0001640334-24-000329 | 32093 | ||||||
| 2024-01-08 | 4 | FORM 4 | 0001640334-24-000025 | 6226 | ||||||
| 2023-11-13 | 10-Q | FORM 10-Q | 0001640334-23-002073 | 001-38951 | 231395253 | 34 | 3831540 | 1 | 1 | |
| 2023-08-10 | 10-Q | FORM 10-Q | 0001640334-23-001504 | 001-38951 | 231157245 | 34 | 3629858 | 1 | 1 | |
| 2023-08-08 | 4 | FORM 4 | 0001640334-23-001492 | 5871 | ||||||
| 2023-08-08 | 4 | FORM 4 | 0001640334-23-001490 | 5928 | ||||||
| 2023-08-08 | 4 | FORM 4 | 0001640334-23-001488 | 5893 | ||||||
| 2023-08-08 | 4 | FORM 4 | 0001640334-23-001486 | 5795 | ||||||
| 2023-08-08 | 4 | FORM 4 | 0001640334-23-001484 | 5936 | ||||||
| 2023-08-08 | 4 | FORM 4 | 0001640334-23-001482 | 6009 | ||||||
| 2023-08-08 | 8-K | FORM 8-K | 5.02 | 0001640334-23-001479 | 001-38951 | 231151993 | 34 | 166297 | 1 | 1 |
| 2023-07-14 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-07-14 16:30:00 | 9999999995-23-002100 | 333-273153 | 231090387 | 33 | 1900 | ||
| 2023-07-12 | CORRESP | filename1.htm | 0001640334-23-001262 | 12733 | ||||||
| 2023-07-10 | UPLOAD | filename1.pdf | 0000000000-23-007304 | 40439 | ||||||
| 2023-07-07 | DEL AM | DEL AM | 0001640334-23-001244 | 333-273153 | 231075249 | 33 | 7578 | |||
| 2023-07-06 | S-3 | FORM S-3 | 0001640334-23-001227 | 333-273153 | 231074007 | 33 | 364825 | |||
| 2023-07-03 | 8-K | FORM 8-K | 5.07 | 0001640334-23-001207 | 001-38951 | 231064737 | 34 | 192614 | 1 | 1 |
| 2023-07-03 | 4 | FORM 4 | 0001640334-23-001205 | 5928 | ||||||
| 2023-07-03 | 4 | FORM 4 | 0001640334-23-001204 | 5791 | ||||||
| 2023-07-03 | 4 | FORM 4 | 0001640334-23-001203 | 5924 | ||||||
| 2023-07-03 | 4 | FORM 4 | 0001640334-23-001202 | 5889 | ||||||
| 2023-07-03 | 4 | FORM 4 | 0001640334-23-001201 | 6006 | ||||||
| 2023-07-03 | 4 | FORM 4 | 0001640334-23-001200 | 5867 | ||||||
| 2023-05-16 | DEFA14A | DEFA 14A | 0001640334-23-000921 | 001-38951 | 23928389 | 34 | 774878 | |||
| 2023-05-16 | DEF 14A | DEF 14A | 0001640334-23-000919 | 001-38951 | 23928382 | 34 | 522067 | |||
| 2023-05-16 | ARS | ARS | 0001140361-23-025051 | 001-38951 | 23928338 | 34 | 1061761 | |||
| 2023-05-11 | 10-Q | FORM 10-Q | 0001640334-23-000804 | 001-38951 | 23908935 | 34 | 5096297 | 1 | 1 | |
| 2023-05-05 | PRE 14A | PRE 14A | 0001640334-23-000777 | 001-38951 | 23894331 | 34 | 508960 | |||
| 2023-04-21 | S-8 | FORM S-8 | 0001640334-23-000696 | 333-271391 | 23836879 | 33 | 79652 | |||
| 2023-04-21 | 8-K | FORM 8-K | 5.03,9.01 | 0001640334-23-000694 | 001-38951 | 23836753 | 34 | 283153 | 1 | 1 |
| 2023-03-31 | 10-K | FORM 10-K | 0001640334-23-000509 | 001-38951 | 23783330 | 34 | 5542661 | 1 | 1 | |
| 2023-03-13 | 8-K | FORM 8-K | 7.01 | 0001640334-23-000334 | 001-38951 | 23725618 | 34 | 146665 | 1 | 1 |
| 2023-02-01 | 4 | FORM 4 | 0001640334-23-000144 | 6053 | ||||||
| 2022-11-08 | 10-Q | FORM 10-Q | 0001640334-22-002363 | 001-38951 | 221367309 | 34 | 3881812 | 1 | 1 | |
| 2022-09-16 | 8-K | FORM 8-K | 5.03,5.07 | 0001640334-22-002036 | 001-38951 | 221248831 | 34 | 154160 | 1 | 1 |
| 2022-08-25 | 8-K | FORM 8-K | 8.01 | 0001640334-22-001896 | 001-38951 | 221193418 | 34 | 147911 | 1 | 1 |
| 2022-08-12 | 4 | FORM 4 | 0001640334-22-001760 | 5245 | ||||||
| 2022-08-11 | 4 | FORM 4 | 0001640334-22-001706 | 5245 | ||||||
| 2022-08-09 | 8-K | FORM 8-K | 3.03,5.03,8.01,9.01 | 0001640334-22-001683 | 001-38951 | 221146495 | 34 | 497979 | 1 | 1 |
| 2022-08-09 | 10-Q | FORM 10-Q | 0001640334-22-001681 | 001-38951 | 221146462 | 34 | 3562168 | 1 | 1 | |
| 2022-07-12 | 8-K | FORM 8-K | 5.07 | 0001640334-22-001477 | 001-38951 | 221079315 | 34 | 192449 | 1 | 1 |
| 2022-06-27 | 4 | FORM 4 | 0001640334-22-001363 | 5782 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001640334-22-001361 | 5706 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001640334-22-001359 | 5843 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001640334-22-001357 | 5829 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001640334-22-001355 | 5804 | ||||||
| 2022-06-27 | 4 | FORM 4 | 0001640334-22-001340 | 5839 | ||||||
| 2022-06-02 | 424B3 | 424B3 | 0001640334-22-001167 | 333-264967 | 22989078 | 33 | 494453 | |||
| 2022-05-31 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2022-05-31 16:30:00 | 9999999995-22-001644 | 333-264967 | 22985838 | 33 | 1899 | ||
| 2022-05-26 | CORRESP | filename1.htm | 0001640334-22-001137 | 9797 | ||||||
| 2022-05-26 | UPLOAD | filename1.pdf | 0000000000-22-005778 | 40352 | ||||||
| 2022-05-26 | DEFA14A | DEFA 14A | 0001640334-22-001135 | 001-38951 | 22965752 | 34 | 670753 | |||
| 2022-05-26 | DEF 14A | DEF 14A | 0001640334-22-001134 | 001-38951 | 22965746 | 34 | 731588 | |||
| 2022-05-20 | D | xslFormDX01/primary_doc.xml | 06b | 0001621221-22-000002 | 021-446459 | 22947131 | 33 | 11277 | ||
| 2022-05-16 | S-1 | FORM S-1 | 0001640334-22-001028 | 333-264967 | 22925740 | 33 | 2113480 | |||
| 2022-05-16 | PRE 14A | PRE 14A | 0001640334-22-001026 | 001-38951 | 22925683 | 34 | 729282 | |||
| 2022-05-16 | 8-K | FORM 8-K | 1.01,3.02,9.01 | 0001640334-22-001024 | 001-38951 | 22925668 | 34 | 519337 | 1 | 1 |
| 2022-05-12 | 10-Q | FORM 10-Q | 0001640334-22-000949 | 001-38951 | 22915850 | 34 | 3239027 | 1 | 1 | |
| 2022-04-07 | S-8 | FORM S-8 | 0001640334-22-000719 | 333-264183 | 22814067 | 33 | 69159 | |||
| 2022-03-21 | 10-KT | FORM 10-KT | 0001640334-22-000544 | 001-38951 | 22754283 | 34 | 5199517 | 1 | 1 | |
| 2022-03-16 | 8-K | FORM 8-K | 8.01 | 0001640334-22-000506 | 001-38951 | 22743223 | 34 | 143911 | 1 | 1 |
| 2022-03-10 | 8-K | FORM 8-K | 5.02,5.03,8.01,9.01 | 0001640334-22-000444 | 001-38951 | 22726893 | 34 | 159981 | 1 | 1 |
| 2022-02-23 | SC 13G/A | c103099_sc13ga.htm | 0000930413-22-000319 | 005-90653 | 22664409 | 34 | 54249 | |||
| 2022-02-09 | SC 13G/A | formsc13ga.htm | 0001493152-22-003557 | 005-90653 | 22605037 | 34 | 217065 | |||
| 2022-02-04 | SC 13G/A | ARTL 13G/A | 0001393825-22-000075 | 005-90653 | 22592835 | 34 | 54407 | |||
| 2022-01-12 | 10-Q | FORM 10-Q | 0001640334-22-000060 | 001-38951 | 22525601 | 34 | 2814233 | 1 | 1 | |
| 2021-12-07 | 8-K | FORM 8-K | 5.02 | 0001640334-21-003064 | 001-38951 | 211476475 | 34 | 148815 | 1 | 1 |
| 2021-12-06 | 4 | FORM 4 SUBMISSION | 0000899243-21-047031 | 6161 | ||||||
| 2021-11-29 | 10-K | FORM 10-K | 0001640334-21-002983 | 001-38951 | 211452993 | 34 | 5347305 | 1 | 1 | |
| 2021-09-17 | 8-K | FORM 8-K | 3.01,5.03 | 0001640334-21-002236 | 001-38951 | 211260748 | 34 | 152005 | 1 | 1 |
| 2021-07-26 | 4 | FORM 4 | 0001640334-21-001686 | 5781 | ||||||
| 2021-07-26 | 4 | FORM 4 | 0001640334-21-001685 | 5803 | ||||||
| 2021-07-26 | 4 | FORM 4 | 0001640334-21-001683 | 5838 | ||||||
| 2021-07-26 | 4 | FORM 4 | 0001640334-21-001681 | 5845 | ||||||
| 2021-07-26 | 4 | FORM 4 | 0001640334-21-001679 | 5705 | ||||||
| 2021-07-26 | 4 | FORM 4 | 0001640334-21-001677 | 5842 | ||||||
| 2021-07-26 | 4 | FORM 4 | 0001640334-21-001675 | 5828 | ||||||
| 2021-07-26 | 8-K | FORM 8-K | 5.02 | 0001640334-21-001665 | 001-38951 | 211112533 | 34 | 16868 | ||
| 2021-07-20 | 8-K | FORM 8-K | 5.07 | 0001640334-21-001601 | 001-38951 | 211099160 | 34 | 35246 | ||
| 2021-07-15 | 8-K | FORM 8-K | 5.03,9.01 | 0001640334-21-001570 | 001-38951 | 211091518 | 34 | 21851 | ||
| 2021-07-12 | 10-Q | FORM 10-Q | 0001640334-21-001528 | 001-38951 | 211084531 | 34 | 3182728 | 1 | ||
| 2021-06-22 | DEFA14A | DEF A14A | 0001640334-21-001399 | 001-38951 | 211036118 | 34 | 26283 | |||
| 2021-05-07 | DEF 14A | FORM DEF 14A | 0001640334-21-001104 | 001-38951 | 21902987 | 34 | 271636 | |||
| 2021-04-20 | 4 | FORM 4 | 0001640334-21-000982 | 5029 | ||||||
| 2021-04-13 | 10-Q | FORM 10-Q | 0001640334-21-000874 | 001-38951 | 21823156 | 34 | 3095736 | 1 | ||
| 2021-04-09 | 8-K | FORM 8-K | 1.01,1.02,9.01 | 0001640334-21-000821 | 001-38951 | 21818211 | 34 | 287838 | ||
| 2021-04-09 | 424B5 | 424B5 | 0001640334-21-000819 | 333-235917 | 21818175 | 33 | 433564 | |||
| 2021-03-09 | 8-K | FORM 8-K | 5.02 | 0001640334-21-000544 | 001-38951 | 21726378 | 34 | 49638 | ||
| 2021-03-09 | 4 | FORM 4 | 0001640334-21-000542 | 6031 | ||||||
| 2021-03-09 | 4 | FORM 4 | 0001640334-21-000540 | 6041 | ||||||
| 2021-03-09 | 3 | FORM 3 | 0001640334-21-000538 | 8216 | ||||||
| 2021-03-01 | SC 13G | formsc13g.htm | 0001493152-21-005110 | 005-90653 | 21698506 | 34 | 209450 | |||
| 2021-02-17 | 4 | FORM 4 | 0001640334-21-000385 | 5864 | ||||||
| 2021-02-17 | 4 | FORM 4 | 0001640334-21-000383 | 5921 | ||||||
| 2021-02-17 | 4 | FORM 4 | 0001640334-21-000381 | 5944 | ||||||
| 2021-02-17 | 4 | FORM 4 | 0001640334-21-000379 | 5928 | ||||||
| 2021-02-17 | 4 | FORM 4 | 0001640334-21-000376 | 5788 | ||||||
| 2021-02-17 | 4 | FORM 4 | 0001640334-21-000373 | 5925 | ||||||
| 2021-02-17 | 8-K | FORM 8-K | 5.02 | 0001640334-21-000370 | 001-38951 | 21645636 | 34 | 17837 | ||
| 2021-02-16 | 8-K | FORM 8-K | 8.01 | 0001640334-21-000356 | 001-38951 | 21641022 | 34 | 18429 | ||
| 2021-02-16 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-023214 | 005-90653 | 21633645 | 34 | 53820 | |||
| 2021-02-10 | SC 13G/A | sc13ga110022artl_02102021.htm | 0000921895-21-000288 | 005-90653 | 21613936 | 34 | 215770 | |||
| 2021-02-08 | SC 13G | ARTL 13G | 0001393825-21-000010 | 005-90653 | 21602355 | 34 | 58937 | |||
| 2021-02-05 | SC 13G/A | ARTELO BIOSCIENCES, INC. | 0000902664-21-000923 | 005-90653 | 21595734 | 34 | 115902 | |||
| 2021-01-21 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001640334-21-000115,2021-01-21 | 9999999995-21-000207 | 333-230658 | 21543641 | 33 | 1906 | ||
| 2021-01-21 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001640334-21-000171,2021-01-21 | 9999999995-21-000211 | 333-249083 | 21543642 | 33 | 1906 | ||
| 2021-01-21 | POS AM | POSAM | 0001640334-21-000171 | 333-249083 | 21540263 | 33 | 112679 | |||
| 2021-01-15 | POS AM | POSAM | 0001640334-21-000115 | 333-230658 | 21532876 | 33 | 106734 | |||
| 2021-01-15 | POS AM | POS AM | 0001640334-21-000114 | 333-230658 | 21532850 | 33 | 108850 | |||
| 2021-01-15 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-21-002440 | 005-90653 | 21530936 | 34 | 41871 | |||
| 2021-01-14 | 10-Q | FORM 10-Q | 0001640334-21-000088 | 001-38951 | 21527554 | 34 | 2445670 | 1 | ||
| 2021-01-13 | SC 13G | ARTELO BIOSCIENCES, INC. | 0000902664-21-000167 | 005-90653 | 21525150 | 34 | 78173 | |||
| 2020-12-16 | S-8 | FORM S-8 | 0001640334-20-003090 | 333-251387 | 201392575 | 33 | 499138 | |||
| 2020-12-07 | 4 | FORM 4 | 0001640334-20-003022 | 5724 | ||||||
| 2020-12-07 | 3 | FORM 3 | 0001640334-20-003020 | 8356 | ||||||
| 2020-12-04 | 8-K | FORM 8-K | 5.07 | 0001640334-20-003010 | 001-38951 | 201370518 | 34 | 23267 | ||
| 2020-12-02 | 8-K | FORM 8-K | 5.02 | 0001640334-20-002991 | 001-38951 | 201363816 | 34 | 19150 | ||
| 2020-11-20 | 8-K | FORM 8-K | 3.01 | 0001640334-20-002910 | 001-38951 | 201332574 | 34 | 17347 | ||
| 2020-11-09 | DEF 14A | DEF 14A | 0001640334-20-002738 | 001-38951 | 201295951 | 34 | 939718 | |||
| 2020-11-04 | 10-K | FORM 10-K | 0001640334-20-002722 | 001-38951 | 201285218 | 34 | 4072270 | 1 | ||
| 2020-10-28 | PRE 14A | PRE 14A | 0001640334-20-002672 | 001-38951 | 201268768 | 34 | 946363 | |||
| 2020-10-26 | SC 13G | SCHEDULE 13G | 0001213900-20-033120 | 005-90653 | 201258965 | 34 | 72111 | |||
| 2020-10-22 | SC 13G | SCHEDULE 13G | 0001213900-20-032762 | 005-90653 | 201253533 | 34 | 55329 | |||
| 2020-10-19 | SC 13G | sc13g10022artl_10192020.htm | 0000921895-20-002643 | 005-90653 | 201246504 | 34 | 234844 | |||
| 2020-10-19 | SC 13G | c100618_sch13g.htm | 0000930413-20-002453 | 005-90653 | 201246128 | 34 | 75364 | |||
| 2020-10-15 | SC 13G | ARTELO BIOSCIENCES, INC. | 0000902664-20-003631 | 005-90653 | 201240711 | 34 | 88278 | |||
| 2020-10-15 | SC 13G | SCHEDULE 13G | 0001104659-20-115170 | 005-90653 | 201240642 | 34 | 83977 | |||
| 2020-10-15 | SC 13G | ARTELO BIOSCIENCES, INC. | 0000902664-20-003628 | 005-90653 | 201240371 | 34 | 115353 | |||
| 2020-10-14 | 8-K | FORM 8-K | 1.01,8.01,9.01 | 0001640334-20-002559 | 001-38951 | 201239221 | 34 | 474427 | ||
| 2020-10-13 | 424B4 | 424B4 - PROSPECTUS | 0001640334-20-002532 | 333-249083 | 201234459 | 33 | 1393272 | |||
| 2020-10-09 | S-1MEF | S-1MEF | 0001640334-20-002507 | 333-249398 | 201232027 | 33 | 94349 | |||
| 2020-10-08 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2020-10-08 17:30:00 | 9999999995-20-002794 | 333-249083 | 201232006 | 33 | 1898 | ||
| 2020-10-08 | S-1/A | FORM S-1/A | 0001640334-20-002503 | 333-249083 | 201231070 | 33 | 125696 | |||
| 2020-10-07 | CORRESP | filename1.htm | 0001640334-20-002496 | 5345 | ||||||
| 2020-10-07 | CORRESP | filename1.htm | 0001640334-20-002495 | 9336 | ||||||
| 2020-10-07 | S-1/A | FORM S-1/A | 0001640334-20-002484 | 333-249083 | 201227880 | 33 | 102922 | |||
| 2020-10-06 | FWP | FWP | 0001640334-20-002473 | 333-249083 | 201225548 | 34 | 3072924 | |||
| 2020-10-06 | S-1/A | FORM S-1 AMENDMENT NO. 1 | 0001640334-20-002471 | 333-249083 | 201225547 | 33 | 6273518 | 1 | ||
| 2020-10-02 | UPLOAD | filename1.pdf | 0000000000-20-009322 | 40341 | ||||||
| 2020-09-28 | S-1 | FORM S-1 | 0001640334-20-002415 | 333-249083 | 201201962 | 33 | 5831778 | 1 | ||
| 2020-07-14 | 8-K | FORM 8-K | 8.01,9.01 | 0001640334-20-001760 | 001-38951 | 201026455 | 34 | 43411 | ||
| 2020-07-14 | 424B5 | 425B5 | 0001640334-20-001759 | 333-235917 | 201026454 | 33 | 12832 | |||
| 2020-07-13 | 10-Q | FORM 10-Q | 0001640334-20-001749 | 001-38951 | 201025626 | 34 | 3106320 | 1 | ||
| 2020-06-26 | 8-K | FORM 8-K | 8.01 | 0001640334-20-001606 | 001-38951 | 20994361 | 34 | 13446 | ||
| 2020-06-25 | S-8 | FORM S-8 | 0001640334-20-001596 | 333-239434 | 20989820 | 33 | 134397 | |||
| 2020-06-22 | 8-K | FORM 8-K | 5.07 | 0001640334-20-001568 | 001-38951 | 20979704 | 34 | 32352 | ||
| 2020-05-19 | 4 | FORM 4 | 0001640334-20-001281 | 7554 | ||||||
| 2020-05-18 | D | xslFormDX01/primary_doc.xml | 06b | 0001621221-20-000001 | 021-367219 | 20890582 | 33 | 10355 | ||
| 2020-05-08 | DEF 14A | DEF 14A | 0001640334-20-001127 | 001-38951 | 20861029 | 34 | 1282817 | |||
| 2020-05-04 | 4 | FORM 4 | 0001640334-20-001029 | 4643 | ||||||
| 2020-05-04 | 4 | FORM 4 | 0001640334-20-001028 | 4723 | ||||||
| 2020-04-22 | UPLOAD | filename1.pdf | 0000000000-20-003450 | 39798 | ||||||
| 2020-04-21 | CORRESP | filename1.htm | 0001640334-20-000903 | 28797 | ||||||
| 2020-04-15 | 424B5 | 424B5 | 0001640334-20-000837 | 333-235917 | 20792474 | 33 | 23589 | |||
| 2020-04-15 | 8-K | FORM 8-K | 1.01,9.01 | 0001640334-20-000835 | 001-38951 | 20792453 | 34 | 239117 | ||
| 2020-04-14 | 424B5 | 424B5 | 0001640334-20-000811 | 333-235917 | 20789802 | 33 | 358174 | |||
| 2020-04-13 | 10-Q | FORM 10-Q | 0001640334-20-000802 | 001-38951 | 20789025 | 34 | 2794220 | 1 | ||
| 2020-04-10 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001640334-20-000737,2020-04-10 | 9999999995-20-000720 | 333-230658 | 20787721 | 33 | 1910 | ||
| 2020-04-07 | UPLOAD | filename1.pdf | 0000000000-20-003006 | 49313 | ||||||
| 2020-04-07 | POS AM | POS AM | 0001640334-20-000737 | 333-230658 | 20778289 | 33 | 7397893 | 1 | ||
| 2020-03-27 | CORRESP | filename1.htm | 0001640334-20-000632 | 35300 | ||||||
| 2020-03-23 | UPLOAD | filename1.pdf | 0000000000-20-002511 | 49093 | ||||||
| 2020-03-11 | 8-K | FORM 8-K | 5.02 | 0001640334-20-000473 | 001-38951 | 20705638 | 34 | 11767 | ||
| 2020-02-14 | 4 | FORM 4 | 0001640334-20-000327 | 5589 | ||||||
| 2020-02-14 | SC 13G | SC 13G | 0001640334-20-000317 | 005-90653 | 20620202 | 34 | 34758 | |||
| 2020-02-14 | SC 13G | SC 13G | 0001640334-20-000316 | 005-90653 | 20620183 | 34 | 36903 | |||
| 2020-02-14 | SC 13G | FORM 13-G | 0001640334-20-000315 | 005-90653 | 20620168 | 34 | 35383 | |||
| 2020-02-07 | 8-K | FORM 8-K | 8.01 | 0001640334-20-000210 | 001-38951 | 20584451 | 34 | 10689 | ||
| 2020-02-03 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-02-03 14:00:00 | 9999999995-20-000214 | 333-235917 | 20570551 | 33 | 1897 | ||
| 2020-02-03 | CORRESP | filename1.htm | 0001640334-20-000182 | 9356 | ||||||
| 2020-01-21 | UPLOAD | filename1.pdf | 0000000000-20-000515 | 46168 | ||||||
| 2020-01-15 | S-3 | FORM S-3 | 0001640334-20-000084 | 333-235917 | 20526964 | 33 | 348061 | |||
| 2020-01-15 | S-8 | FORM S-8 | 0001640334-20-000082 | 333-235916 | 20526960 | 33 | 995895 | |||
| 2020-01-14 | 10-Q | FORM 10-Q | 0001640334-20-000071 | 001-38951 | 20524974 | 34 | 2342724 | 1 | ||
| 2020-01-14 | 8-K | FORM 8-K | 2.02,9.01 | 0001640334-20-000073 | 001-38951 | 20524973 | 34 | 159644 | ||
| 2020-01-03 | SC 13G/A | SC 13G/A | 0001104659-20-000711 | 005-90653 | 20504353 | 34 | 69599 | |||
| 2019-12-20 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2019-12-20 16:00:00 | 9999999995-19-002888 | 333-234372 | 191303344 | 33 | 1898 | ||
| 2019-12-20 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2019-12-20 16:00:00 | 9999999995-19-002879 | 333-232853 | 191303335 | 33 | 1898 | ||
| 2019-12-19 | CORRESP | filename1.htm | 0001640334-19-002627 | 10024 | ||||||
| 2019-12-19 | CORRESP | filename1.htm | 0001640334-19-002625 | 10045 | ||||||
| 2019-12-19 | S-3/A | FORM S-3 AMENDMENT NO. 2 | 0001640334-19-002622 | 333-232853 | 191294013 | 33 | 346490 | |||
| 2019-12-18 | 10-K/A | FORM 10-K AMENDMENT NO. 1 | 0001640334-19-002608 | 001-38951 | 191291174 | 34 | 3237747 | 1 | ||
| 2019-12-13 | 4 | FORM 4 | 0001640334-19-002583 | 8257 | ||||||
| 2019-12-13 | 3 | FORM 3 | 0001640334-19-002582 | 7874 | ||||||
| 2019-12-06 | 8-K | FORM 8-K | 5.02 | 0001640334-19-002544 | 001-38951 | 191273253 | 34 | 17079 | ||
| 2019-11-25 | S-3/A | FORM S-3 AMENDMENT NO. 1 | 0001640334-19-002450 | 333-234372 | 191243832 | 33 | 349477 | |||
| 2019-11-25 | S-3/A | FORM S-3 AMENDMENT NO. 1 | 0001640334-19-002446 | 333-232853 | 191243806 | 33 | 384694 | |||
| 2019-11-25 | 10-K | FORM 10-K | 0001640334-19-002443 | 001-38951 | 191243720 | 34 | 3781969 | 1 | ||
| 2019-11-15 | 8-K | FORM 8-K | 7.01,9.01 | 0001640334-19-002370 | 001-38951 | 191225157 | 34 | 7074540 | ||
| 2019-11-12 | CORRESP | filename1.htm | 0001640334-19-002235 | 4526 | ||||||
| 2019-11-08 | CORRESP | filename1.htm | 0001640334-19-002217 | 9412 | ||||||
| 2019-11-08 | UPLOAD | filename1.pdf | 0000000000-19-015344 | 46214 | ||||||
| 2019-11-05 | 4 | FORM 4 | 0001640334-19-002181 | 5036 | ||||||
| 2019-11-01 | 4 | FORM 4 | 0001640334-19-002169 | 8672 | ||||||
| 2019-10-30 | S-3 | FORM S-3 | 0001640334-19-002145 | 333-234372 | 191177201 | 33 | 386894 | |||
| 2019-10-17 | 4 | FORM 4 | 0001640334-19-002067 | 5034 | ||||||
| 2019-10-11 | 4 | FORM 4 | 0001640334-19-002035 | 5035 | ||||||
| 2019-09-06 | 8-K | FROM 8-K | 5.02 | 0001640334-19-001804 | 001-38951 | 191080040 | 34 | 17314 | ||
| 2019-08-30 | 4 | FORM 4 | 0001640334-19-001786 | 5705 | ||||||
| 2019-08-30 | 4 | FORM 4 | 0001640334-19-001783 | 5568 | ||||||
| 2019-08-30 | 4 | FORM 4 | 0001640334-19-001781 | 5773 | ||||||
| 2019-08-30 | 4 | FORM 4 | 0001640334-19-001779 | 5649 | ||||||
| 2019-08-30 | 4 | FORM 4 | 0001640334-19-001777 | 5701 | ||||||
| 2019-08-30 | 4 | FORM 4 | 0001640334-19-001775 | 5644 | ||||||
| 2019-07-31 | UPLOAD | filename1.pdf | 0000000000-19-011880 | 46164 | ||||||
| 2019-07-26 | S-3 | FORM S-3 | 0001640334-19-001468 | 333-232853 | 19978203 | 33 | 353184 | |||
| 2019-07-15 | 8-K | FORM 8-K | 2.02,9.01 | 0001640334-19-001363 | 001-38951 | 19955436 | 34 | 41149 | ||
| 2019-07-15 | 10-Q | FORM 10-Q | 0001640334-19-001361 | 001-38951 | 19955245 | 34 | 2465259 | 1 | ||
| 2019-06-25 | 8-K | FORM 8-K | 1.01,5.03,8.01,9.01 | 0001640334-19-001230 | 001-38951 | 19918560 | 34 | 1146601 | ||
| 2019-06-25 | 424B4 | PROSPECTUS | 0001640334-19-001225 | 333-230658 | 19916716 | 33 | 3892806 | |||
| 2019-06-21 | 3 | FORM 3 | 0001640334-19-001211 | 9354 | ||||||
| 2019-06-21 | 3 | FORM 3 | 0001640334-19-001210 | 7697 | ||||||
| 2019-06-21 | 3 | FORM 3 | 0001640334-19-001209 | 9927 | ||||||
| 2019-06-21 | 3 | FORM 3 | 0001640334-19-001208 | 7793 | ||||||
| 2019-06-21 | 3 | FORM 3 | 0001640334-19-001207 | 7682 | ||||||
| 2019-06-21 | 3 | FORM 3 | 0001640334-19-001206 | 8830 | ||||||
| 2019-06-21 | 3 | FORM 3 | 0001640334-19-001205 | 9912 | ||||||
| 2019-06-21 | 3 | FORM 3 | 0001640334-19-001204 | 8046 | ||||||
| 2019-06-21 | CERT | 8A_Cert_ARTL.pdf | 0001354457-19-000327 | 001-38951 | 19910872 | 34 | 80376 | |||
| 2019-06-21 | 8-A12B | 8-A12B | 0001640334-19-001191 | 001-38951 | 19909634 | 34 | 13314 | |||
| 2019-06-20 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2019-06-20 17:00:00 | 9999999995-19-001390 | 333-230658 | 19909748 | 33 | 1897 | ||
| 2019-06-20 | CORRESP | filename1.htm | 0001640334-19-001183 | 7641 | ||||||
| 2019-06-20 | CORRESP | filename1.htm | 0001640334-19-001182 | 8909 | ||||||
| 2019-06-20 | S-1/A | FORM S-1/A | 0001640334-19-001174 | 333-230658 | 19907430 | 33 | 1495478 | |||
| 2019-06-10 | S-1/A | FORM S-1 AMENDMENT NO. 3 | 0001640334-19-001091 | 333-230658 | 19887503 | 33 | 7046059 | 1 | ||
| 2019-06-04 | D | xslFormDX01/primary_doc.xml | 06b | 0001640334-19-001043 | 021-341134 | 19877236 | 33 | 10278 | ||
| 2019-06-04 | D | xslFormDX01/primary_doc.xml | 06b | 0001640334-19-001041 | 021-341133 | 19877214 | 33 | 10393 | ||
| 2019-05-31 | S-1/A | FORM S-1 AMENDMENT NO. 2 | 0001640334-19-001007 | 333-230658 | 19871132 | 33 | 7046795 | 1 | ||
| 2019-05-29 | S-1/A | FORM S-1 AMENDMENT NO. 1 | 0001640334-19-001003 | 333-230658 | 19863397 | 33 | 7088187 | 1 | ||
| 2019-04-30 | 8-K | FORM 8-K | 1.01,3.02,8.01 | 0001640334-19-000730 | 333-199213 | 19782932 | 34 | 14344 | ||
| 2019-04-15 | 10-Q | FORM 10-Q | 0001640334-19-000608 | 333-199213 | 19748859 | 34 | 2150518 | 1 | ||
| 2019-04-01 | S-1 | FORM S-1 | 0001640334-19-000498 | 333-230658 | 19721133 | 33 | 3555610 | 1 | ||
| 2019-03-08 | 8-K | FORM 8-K | 8.01 | 0001640334-19-000362 | 333-199213 | 19667302 | 34 | 10986 | ||
| 2019-03-07 | 8-K | FORM 8-K | 5.02 | 0001640334-19-000358 | 333-199213 | 19663879 | 34 | 11909 | ||
| 2019-02-11 | SC 13G/A | SC 13G/A | 0001144204-19-006177 | 005-90653 | 19584408 | 34 | 65626 | |||
| 2019-01-14 | 10-Q | FORM 10-Q | 0001640334-19-000036 | 333-199213 | 19525551 | 34 | 1116181 | 1 | ||
| 2018-11-29 | 10-K | FORM 10-K | 0001640334-18-002309 | 333-199213 | 181209237 | 34 | 2550787 | 1 | ||
| 2018-10-09 | 8-K | FORM 8-K | 8.01,9.01 | 0001640334-18-001881 | 333-199213 | 181112348 | 34 | 34140 | ||
| 2018-10-05 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2018-10-05 17:00:00 | 9999999995-18-002562 | 333-227571 | 181111756 | 33 | 1898 | ||
| 2018-10-04 | UPLOAD | filename1.pdf | 0000000000-18-031298 | 46143 |
One latest value per concept from companyfacts (287 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 937,177 | 2026-11-11 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 9.29M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-24 | 0001640334-26-000368 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 53,296 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-05 | 0001640334-26-001007 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 41,667 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-05 | 0001640334-26-001007 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 883,189 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-05 | 0001640334-26-001007 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 1.21M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-05 | 0001640334-26-001007 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 7,070 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-06-05 | 0001640334-26-001007 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 788 | 2026-05-02 | S-3 | 2026-05-04 | 0001640334-26-000820 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 788.05 | 2026-05-02 | S-3 | 2026-05-04 | 0001640334-26-000820 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 75.00M | 2026-05-02 | S-3 | 2026-05-04 | 0001640334-26-000820 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-05-02 | S-3 | 2026-05-04 | 0001640334-26-000820 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-05-02 | S-3 | 2026-05-04 | 0001640334-26-000820 | |||
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 284,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 418,943 | 2021-05-31 | 2021 | Q3 | 10-Q | 2021-07-12 | 0001640334-21-001528 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 639,417 | 2019-08-31 | 2020 | Q3 | 10-Q | 2020-07-13 | 0001640334-20-001749 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 0 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001640334-26-001323 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1,584 | 2021-05-31 | 2021 | Q3 | 10-Q | 2021-07-12 | 0001640334-21-001528 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -242,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 76.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 55,616 | 2017-02-28 | 2017 | Q2 | 10-Q | 2017-04-14 | 0001640334-17-000697 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 145,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 1.02M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0001640334-24-000473 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 15,151 | 2019-09-01 | 2019-11-30 | 2021 | Q3 | 10-Q | 2021-07-12 | 0001640334-21-001528 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation | USD | 1.50M | 2020-09-01 | 2021-08-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 256,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001640334-26-000869 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 600 | 2016-09-01 | 2017-08-31 | 2018 | FY | 10-K | 2018-11-29 | 0001640334-18-002309 |
| us-gaap | AmortizationOfDeferredCharges | Amortization of Deferred Charges | USD | 83,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 169 | 2016-09-01 | 2017-02-28 | 2017 | Q2 | 10-Q | 2017-04-14 | 0001640334-17-000697 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 807,326 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | Assets | Assets | USD | 6.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 4.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedLoss | Debt Securities, Available-for-sale, Unrealized Loss | USD | 24,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-31 | 0001640334-23-000509 |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 1.49M | 2022-06-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001640334-22-002363 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 1.52M | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 | |
| us-gaap | AvailableForSaleSecuritiesCurrent | Available-for-sale Securities, Current | USD | 1.99M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0001640334-22-001681 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0001640334-24-000473 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0001640334-24-000473 | |
| us-gaap | AvailableForSaleSecuritiesGrossUnrealizedLoss | Available-for-sale Securities, Gross Unrealized Loss | USD | 29,000 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0001640334-22-001681 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 4,198 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 7.42M | 2021-09-01 | 2021-11-30 | 2022 | Q1 | 10-Q | 2022-01-12 | 0001640334-22-000060 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 4.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 3.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 1.72M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001640334-25-002022 | |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 250,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 | Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments | USD | 8,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-31 | 0001640334-23-000509 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0.001 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001640334-26-000869 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight | Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares | 1 | 2019-06-25 | 2019 | FY | 10-K/A | 2019-12-18 | 0001640334-19-002608 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 10.12M | 2020-10-14 | 2021 | Q3 | 10-Q | 2021-07-12 | 0001640334-21-001528 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 4.43B | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 | |
| us-gaap | CommonStockNoParValue | Common Stock, No Par Value | USD/shares | 0.001 | 2025-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | |||
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 55.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | CommonStockSharesHeldInEmployeeTrust | Common Stock, Shares Held in Employee Trust | USD | 6.50M | 2025-07-18 | 8-K | 2026-03-17 | 0001640334-26-000461 | |||
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 937,177 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 937,177 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | CommonStockShareSubscribedButUnissuedSubscriptionsReceivable | Common Stock, Share Subscribed but Unissued, Subscriptions Receivable | USD | 600 | 2016-08-31 | 2017 | FY | 10-K | 2017-11-29 | 0001640334-17-002551 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -7.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 208,000 | 2026-01-01 | 2026-03-31 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001640334-26-001323 |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 791,000 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-13 | 0001640334-25-001429 | |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | CryptoAssetFairValue | CryptoAssetFairValue | USD | 325,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001640334-25-002022 | |
| us-gaap | DebtConversionOriginalDebtAmount1 | Debt Conversion, Original Debt, Amount | USD | 55,000 | 2025-01-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 91.8 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 665,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | DebtInstrumentIncreaseAccruedInterest | Debt Instrument, Increase, Accrued Interest | USD | 23,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.12 | 2025-10-28 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | DebtInstrumentUnamortizedDiscountCurrent | Debt Instrument, Unamortized Discount, Current | USD | 431 | 2017-05-31 | 2017 | Q3 | 10-Q | 2017-07-21 | 0001640334-17-001454 | |
| us-gaap | DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1 | Debtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net | USD | 720,000 | 2026-04-01 | 2026-04-02 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostCurrent | Debt Securities, Available-for-sale, Amortized Cost, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0001640334-24-000473 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent | Debt Securities, Available-for-sale, Amortized Cost, Noncurrent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-31 | 0001640334-23-000509 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedGainLoss | Debt Securities, Available-for-sale, Unrealized Gain (Loss) | USD | 0 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0001640334-24-001221 |
| us-gaap | DebtSecuritiesNoncurrent | Debt Securities, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0001640334-24-000473 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 424,000 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-13 | 0001640334-25-000825 | |
| us-gaap | DeferredCostsCurrent | Deferred Costs, Current | USD | 291,670 | 2019-05-31 | 2019 | Q3 | 10-Q | 2019-07-15 | 0001640334-19-001361 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 424,000 | 2025-03-31 | 8-K | 2025-07-11 | 0001640334-25-001184 | |||
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2025-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 1.80M | 2020-08-31 | 2020 | FY | 10-K | 2020-11-04 | 0001640334-20-002722 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 7.82M | 2025-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | |||
| us-gaap | DepositAssets | Deposit Assets | USD | 250,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001640334-25-002022 | |
| us-gaap | DepositsAssetsCurrent | Deposits Assets, Current | USD | 1,500 | 2020-02-29 | 2020 | Q2 | 10-Q | 2020-04-13 | 0001640334-20-000802 | |
| us-gaap | Depreciation | Depreciation | USD | 183 | 2020-09-01 | 2021-05-31 | 2021 | Q3 | 10-Q | 2021-07-12 | 0001640334-21-001528 |
| us-gaap | DepreciationNonproduction | Depreciation, Nonproduction | USD | 500 | 2019-09-01 | 2020-08-31 | 2020 | FY | 10-K | 2020-11-04 | 0001640334-20-002722 |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | -146,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | DerivativeLiabilities | Derivative Liability | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 582,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001640334-26-000869 | |
| us-gaap | DerivativeLossOnDerivative | Derivative, Loss on Derivative | USD | 456,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 23,419 | 2015-02-28 | 2015 | Q2 | 10-Q | 2015-04-14 | 0001557240-15-000242 | |
| us-gaap | DueFromRelatedParties | Due from Related Parties | USD | 65,000 | 2018-01-26 | 2018 | Q3 | 10-Q | 2018-07-13 | 0001640334-18-001368 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 87,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001640334-23-000804 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.79 | 2019-09-01 | 2020-02-29 | 2020 | Q2 | 10-Q | 2020-04-13 | 0001640334-20-000802 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.12 | 2021-09-01 | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -19.48 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.253 | 2017-09-01 | 2018-08-31 | 2019 | FY | 10-K/A | 2019-12-18 | 0001640334-19-002608 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations | Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations | USD | -28,000 | 2021-09-01 | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 29,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensation | Employee Benefits and Share-based Compensation | USD | 216,000 | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001640334-26-001323 |
| us-gaap | EquityIssuancePerShareAmount | Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) | USD | 0.005 | 2013-09-01 | 2014-08-31 | 2015 | Q2 | 10-Q | 2015-04-14 | 0001557240-15-000242 |
| us-gaap | ExtinguishmentOfDebtAmount | Extinguishment of Debt, Amount | USD | 522,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | ExtinguishmentOfDebtGainLossNetOfTax | Extinguishment of Debt, Gain (Loss), Net of Tax | USD | -1.16M | 2025-01-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | FederalDepositInsuranceCorporationPremiumExpense | Federal Deposit Insurance Corporation Premium Expense | USD | 9.20M | 2020-09-01 | 2021-05-31 | 2021 | Q3 | 10-Q | 2021-07-12 | 0001640334-21-001528 |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 2.04M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0001640334-24-000473 | |
| us-gaap | GainLossOnInvestments | Gain (Loss) on Investments | USD | 22,000 | 2025-01-01 | 2025-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | ||
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 42,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 4.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | IncomeLossFromContinuingOperations | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | USD | -4.04M | 2021-09-01 | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | IncomeTaxCreditsAndAdjustments | Income Tax Credits and Adjustments | USD | 1.21M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0001640334-24-000473 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001640334-26-001323 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 519,532 | 2017-09-01 | 2018-08-31 | 2018 | FY | 10-K | 2018-11-29 | 0001640334-18-002309 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -519,532 | 2017-09-01 | 2018-08-31 | 2018 | FY | 10-K | 2018-11-29 | 0001640334-18-002309 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount | USD | 1.35M | 2024-01-01 | 2024-12-31 | 8-K | 2025-07-11 | 0001640334-25-001184 | ||
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 29,000 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0001640334-22-001681 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -2.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | IncreaseDecreaseInAccountsPayableRelatedParties | Increase (Decrease) in Accounts Payable, Related Parties | USD | -221,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 15,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | IncreaseDecreaseInDeferredFuelCosts | Increase (Decrease) in Deferred Fuel Costs | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001640334-26-000869 |
| us-gaap | IncreaseDecreaseInDueToRelatedParties | Increase (Decrease) in Due to Related Parties | USD | 11,000 | 2021-09-01 | 2021-11-30 | 2022 | Q1 | 10-Q | 2022-01-12 | 0001640334-22-000060 |
| us-gaap | IncreaseDecreaseInDueToRelatedPartiesCurrent | Increase (Decrease) in Due to Related Parties, Current | USD | 22,000 | 2021-09-01 | 2021-11-30 | 2022 | Q1 | 10-Q | 2022-01-12 | 0001640334-22-000060 |
| us-gaap | IncreaseDecreaseInInterestPayableNet | Increase (Decrease) in Interest Payable, Net | USD | 48,000 | 2025-01-01 | 2025-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | ||
| us-gaap | IncreaseDecreaseInMarketableSecuritiesRestricted | Increase (Decrease) in Marketable Securities, Restricted | USD | -2,319 | 2020-09-01 | 2021-05-31 | 2021 | Q3 | 10-Q | 2021-07-12 | 0001640334-21-001528 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -29,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | 20,771 | 2019-09-01 | 2020-02-29 | 2020 | Q2 | 10-Q | 2020-04-13 | 0001640334-20-000802 |
| us-gaap | IncreaseDecreaseInOtherReceivables | Increase (Decrease) in Other Receivables | USD | -13,340 | 2018-09-01 | 2019-08-31 | 2020 | FY | 10-K | 2020-11-04 | 0001640334-20-002722 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 65,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 169,264 | 2019-09-01 | 2020-08-31 | 2020 | FY | 10-K | 2020-11-04 | 0001640334-20-002722 |
| us-gaap | IncreaseDecreaseInPrepaidExpensesOther | Increase (Decrease) in Prepaid Expenses, Other | USD | -5,000 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0001640334-24-000757 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 2.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0001640334-24-000473 |
| us-gaap | InterestExpense | Interest Expense | USD | 106,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | InterestExpenseOther | Interest Expense, Other | USD | 106,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 67,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 0 | 2017-09-01 | 2018-02-28 | 2018 | Q2 | 10-Q/A | 2018-05-14 | 0001640334-18-000943 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | InvestmentsFairValueDisclosure | Investments, Fair Value Disclosure | USD | 6.41M | 2024-12-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0001640334-24-000757 | |
| us-gaap | Liabilities | Liabilities | USD | 439,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 6.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 439,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 0 | 2024-12-31 | 8-K | 2025-07-11 | 0001640334-25-001184 | |||
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001640334-25-002022 | |
| us-gaap | MarketableSecuritiesGainLoss | Marketable Securities, Gain (Loss) | USD | 248,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0001640334-24-001677 |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 0 | 2024-12-31 | 8-K | 2025-07-11 | 0001640334-25-001184 | |||
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | 2,140 | 2020-09-01 | 2021-02-28 | 2021 | Q2 | 10-Q | 2021-04-13 | 0001640334-21-000874 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 12.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 592,877 | 2017-09-01 | 2018-02-28 | 2018 | Q2 | 10-Q/A | 2018-05-14 | 0001640334-18-000943 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -887 | 2017-09-01 | 2018-02-28 | 2018 | Q2 | 10-Q/A | 2018-05-14 | 0001640334-18-000943 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -8.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -637,379 | 2017-09-01 | 2018-02-28 | 2018 | Q2 | 10-Q/A | 2018-05-14 | 0001640334-18-000943 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -7.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | NoninterestExpenseOfferingCost | Noninterest Expense Offering Cost | USD | 130,000 | 2025-09-02 | 2025-09-04 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001640334-25-002022 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -167,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 29,720 | 2017-05-31 | 2017 | Q3 | 10-Q | 2017-07-21 | 0001640334-17-001454 | |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 6.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -6.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 87,000 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-13 | 0001640334-24-001221 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 40,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 15,000 | 2026-04-01 | 2026-04-14 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 37,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 37.78M | 2025-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | |||
| us-gaap | OtherAssets | Other Assets | USD | 3,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 3,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001640334-23-000804 | |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | 30,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | 30,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | 51,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0001640334-24-000473 |
| us-gaap | OtherComprehensiveIncomeLossTax | Other Comprehensive Income (Loss), Tax | USD | 49,000 | 2023-01-01 | 2023-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0001640334-24-000757 |
| us-gaap | OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 | Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent | USD | 49,000 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001640334-23-000804 |
| us-gaap | OtherNoncashExpense | Other Noncash Expense | USD | 28,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 567 | 2020-09-01 | 2020-11-30 | 2021 | Q1 | 10-Q | 2021-01-14 | 0001640334-21-000088 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 3,775 | 2020-09-01 | 2021-05-31 | 2021 | Q3 | 10-Q | 2021-07-12 | 0001640334-21-001528 |
| us-gaap | OtherReceivablesGrossCurrent | Other Receivables, Gross, Current | USD | 29,558 | 2020-02-29 | 2020 | Q2 | 10-Q | 2020-04-13 | 0001640334-20-000802 | |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 16,484 | 2018-05-31 | 2018 | Q3 | 10-Q | 2018-07-13 | 0001640334-18-001368 | |
| us-gaap | PaymentForAcquisitionCryptoAsset | PaymentForAcquisitionCryptoAsset | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | PaymentsForProceedsFromProductiveAssets | Payments for (Proceeds from) Productive Assets | USD | -188,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-24 | 0001640334-26-000368 |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 45,000 | 2026-04-01 | 2026-04-14 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | PaymentsForRepurchaseOfInitialPublicOffering | Payments for Repurchase of Initial Public Offering | USD | 75.00M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001640334-25-002022 |
| us-gaap | PaymentsOfDebtExtinguishmentCosts | Payment for Debt Extinguishment or Debt Prepayment Cost | USD | 582,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-13 | 0001640334-23-002073 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecurities | Payments to Acquire Available-for-sale Securities | USD | 1.52M | 2021-09-01 | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0001640334-24-000473 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 1.50M | 2021-09-01 | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | PaymentsToAcquireMachineryAndEquipment | Payments to Acquire Machinery and Equipment | USD | 688 | 2018-09-01 | 2019-08-31 | 2020 | FY | 10-K | 2020-11-04 | 0001640334-20-002722 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 0 | 2025-01-01 | 2025-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | ||
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 1,176 | 2019-09-01 | 2020-05-31 | 2021 | Q3 | 10-Q | 2021-07-12 | 0001640334-21-001528 |
| us-gaap | PaymentsToEmployees | Payments to Employees | USD | 12,340 | 2017-09-01 | 2018-02-28 | 2018 | Q2 | 10-Q/A | 2018-05-14 | 0001640334-18-000943 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 23,148 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 159,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 903,000 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0001640334-23-000804 | |
| us-gaap | PrepaidExpenseNoncurrent | Prepaid Expense, Noncurrent | USD | 3,000 | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 593,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | ProceedsFromDerivativeInstrumentFinancingActivities | Proceeds from Derivative Instrument, Financing Activities | USD | 300,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | ProceedsFromFeesReceived | Proceeds from Fees Received | USD | 18,262 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-31 | 0001640334-23-000509 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 18.26M | 2024-01-01 | 2024-12-31 | 8-K | 2025-07-11 | 0001640334-25-001184 | ||
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 13.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | ProceedsFromIssuanceOfDebt | Proceeds from Issuance of Debt | USD | 593,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001640334-26-001323 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 55,000 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0001640334-24-000757 |
| us-gaap | ProceedsFromIssuanceOfUnsecuredDebt | Proceeds from Issuance of Unsecured Debt | USD | 610,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 1.08M | 2025-01-01 | 2025-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | ||
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 75.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 5,000 | 2021-09-01 | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 29,400 | 2016-09-01 | 2017-08-31 | 2018 | FY | 10-K | 2018-11-29 | 0001640334-18-002309 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-31 | 0001640334-23-000509 |
| us-gaap | ProceedsFromRepaymentsOfNotesPayable | Proceeds from (Repayments of) Notes Payable | USD | -30,000 | 2016-09-01 | 2017-08-31 | 2018 | FY | 10-K | 2018-11-29 | 0001640334-18-002309 |
| us-gaap | ProceedsFromRepaymentsOfRelatedPartyDebt | Proceeds from (Repayments of) Related Party Debt | USD | 0 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0001640334-22-001681 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 0 | 2025-01-01 | 2025-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | ||
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 1.51M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0001640334-24-000473 |
| us-gaap | ProceedsFromSaleOfFederalReserveStock | Proceeds from Sale of Federal Reserve Bank Stock | USD | 75.00M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001640334-25-002022 |
| us-gaap | ProceedsFromSaleOfTradingSecuritiesHeldforinvestment | Proceeds from Sale of Debt and Equity Securities, FV-NI, Held-for-investment | USD | 2.69M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0001640334-22-001681 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 237,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | ProfessionalFees | Professional Fees | USD | 26,000 | 2021-09-01 | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -2.43M | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001640334-26-001323 |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 63 | 2021-05-31 | 2021 | Q3 | 10-Q | 2021-07-12 | 0001640334-21-001528 | |
| us-gaap | RelatedPartyTransactionAmountsOfTransaction | Related Party Transaction, Amounts of Transaction | USD | 230,000 | 2016-09-01 | 2017-05-31 | 2017 | Q3 | 10-Q | 2017-07-21 | 0001640334-17-001454 |
| us-gaap | RelatedPartyTransactionDueFromToRelatedParty | Related Party Transaction, Due from (to) Related Party | USD | 150,000 | 2017-05-31 | 2017 | Q3 | 10-Q | 2017-07-21 | 0001640334-17-001454 | |
| us-gaap | RepaymentsOfConvertibleDebt | Repayments of Convertible Debt | USD | 1.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 430,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001640334-26-000869 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 207,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 2.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -70.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 7,000 | 2021-09-01 | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | SalariesAndWages | Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold | USD | 125,000 | 2018-01-01 | 2018-01-26 | 2018 | Q2 | 10-Q/A | 2018-05-14 | 0001640334-18-000943 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 20.00M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-13 | 0001640334-25-001429 |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 1.30B | 2019-06-01 | 2019-06-25 | 2021 | FY | 10-K | 2021-11-29 | 0001640334-21-002983 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 1.51 | 2021-05-31 | 2021 | Q3 | 10-Q | 2021-07-12 | 0001640334-21-001528 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 617,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.55 | 2019-09-01 | 2020-08-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.98 | 2025-01-01 | 2025-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.97 | 2025-01-01 | 2025-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.039 | 2025-01-01 | 2025-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.044 | 2024-01-01 | 2024-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.04 | 2024-01-01 | 2024-12-31 | 8-K | 2026-03-17 | 0001640334-26-000461 | ||
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 0 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001640334-22-002363 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 90,315 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001640334-22-002363 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 37.71 | 2021-12-31 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001640334-22-002363 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 24,838 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001640334-22-002363 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 25.69 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001640334-22-002363 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 74.00M | 2019-09-01 | 2020-08-31 | 2022 | FY | 10-K | 2023-03-31 | 0001640334-23-000509 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 0.63 | 2021-09-01 | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | USD/shares | 24.15 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001640334-22-002363 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 0 | 2020-08-31 | 2021 | FY | 10-K | 2021-11-29 | 0001640334-21-002983 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 313,109 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001640334-22-002363 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 3.57 | 2020-08-31 | 2020 | FY | 10-K | 2020-11-04 | 0001640334-20-002722 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 878,017 | 2018-09-01 | 2019-08-31 | 2019 | FY | 10-K/A | 2019-12-18 | 0001640334-19-002608 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | shares | 25.00M | 2018-08-01 | 2018-08-17 | 2022 | FY | 10-K | 2023-03-31 | 0001640334-23-000509 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001640334-22-002363 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 4.89 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001640334-22-002363 |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price | USD/shares | 3.92 | 2020-08-31 | 2020 | FY | 10-K | 2020-11-04 | 0001640334-20-002722 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | shares | 151,505 | 2020-08-31 | 2020 | FY | 10-K | 2020-11-04 | 0001640334-20-002722 | |
| us-gaap | SharePrice | Share Price | USD/shares | 0.95 | 2019-04-12 | 2019 | Q2 | 10-Q | 2019-04-15 | 0001640334-19-000608 | |
| us-gaap | SharesIssued | Shares, Issued | shares | 575,000 | 2017-05-31 | 2017 | Q3 | 10-Q | 2017-07-21 | 0001640334-17-001454 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 0.65 | 2018-01-26 | 2018 | Q3 | 10-Q | 2018-07-13 | 0001640334-18-001368 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 6.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 38,741 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-25 | 0001640334-24-000473 |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfUnits | Stock Issued During Period, Shares, Conversion of Units | shares | 2,264 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForServices | Stock Issued During Period, Shares, Issued for Services | shares | 15,348 | 2024-01-01 | 2024-12-31 | 8-K | 2025-07-11 | 0001640334-25-001184 | ||
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 153,351 | 2025-06-01 | 2025-06-26 | 8-K | 2026-03-17 | 0001640334-26-000461 | ||
| us-gaap | StockIssuedDuringPeriodSharesOther | Stock Issued During Period, Shares, Other | shares | 70,897 | 2024-01-01 | 2024-12-31 | 8-K | 2025-07-11 | 0001640334-25-001184 | ||
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardGross | Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares | 520,000 | 2017-09-01 | 2018-08-31 | 2018 | FY | 10-K | 2018-11-29 | 0001640334-18-002309 |
| us-gaap | StockIssuedDuringPeriodSharesReverseStockSplits | Stock Issued During Period, Shares, Reverse Stock Splits | shares | 10 | 2018-09-01 | 2019-08-31 | 2019 | FY | 10-K/A | 2019-12-18 | 0001640334-19-002608 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 0 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0001640334-22-001681 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 539,000 | 2019-09-01 | 2020-08-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 208,000 | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments | Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments | USD | 100,000 | 2019-09-01 | 2020-08-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 208,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForCash | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) | USD | 30,000 | 2013-09-01 | 2014-08-31 | 2015 | Q2 | 10-Q | 2015-04-14 | 0001557240-15-000242 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 112,000 | 2024-01-01 | 2024-12-31 | 8-K | 2025-07-11 | 0001640334-25-001184 | ||
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 2.86M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 679,000 | 2024-01-01 | 2024-12-31 | 8-K | 2025-07-11 | 0001640334-25-001184 | ||
| us-gaap | StockOptionExercisePriceIncrease | Stock Option, Exercise Price, Increase | USD/shares | 17.46 | 2025-06-01 | 2025-06-26 | 8-K | 2026-03-17 | 0001640334-26-000461 | ||
| us-gaap | StockOptionPlanExpense | Stock or Unit Option Plan Expense | USD | 100,000 | 2018-09-01 | 2019-08-31 | 2020 | FY | 10-K | 2020-11-04 | 0001640334-20-002722 |
| us-gaap | StockRedeemedOrCalledDuringPeriodValue | Stock Redeemed or Called During Period, Value | USD | -2,500 | 2019-12-01 | 2020-02-29 | 2021 | Q3 | 10-Q | 2021-07-12 | 0001640334-21-001528 |
| us-gaap | StockRepurchasedAndRetiredDuringPeriodValue | Stock Repurchased and Retired During Period, Value | USD | -400 | 2016-09-01 | 2017-08-31 | 2018 | FY | 10-K | 2018-11-29 | 0001640334-18-002309 |
| us-gaap | UnamortizedDebtIssuanceExpense | Unamortized Debt Issuance Expense | USD | 2.36M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001640334-22-002363 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -5,000 | 2021-09-01 | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | WarrantExercisePriceDecrease | Warrant, Exercise Price, Decrease | USD/shares | 168.48 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 5.64M | 2019-02-28 | 2019 | Q2 | 10-Q | 2019-04-15 | 0001640334-19-000608 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 367,161 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001640334-26-001776 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 33.45B | 2021-09-01 | 2021-12-31 | 2022 | Q1 | 10-KT | 2022-03-21 | 0001640334-22-000544 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 3.39M | 2019-09-01 | 2020-02-29 | 2020 | Q2 | 10-Q | 2020-04-13 | 0001640334-20-000802 |